Armata Pharmaceuticals, Inc.·4

Dec 26, 9:54 PM ET

Rychlik Richard 4

4 · Armata Pharmaceuticals, Inc. · Filed Dec 26, 2023

Insider Transaction Report

Form 4
Period: 2023-12-21
Rychlik Richard
Corporate Controller and PFO
Transactions
  • Award

    Stock Options (Right to Buy)

    2023-12-21+50,00050,000 total
    Exercise: $2.39Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The Option shall vest in equal annual installments on each of the first four anniversaries of September 5, 2023.

Documents

1 file
  • 4
    tm2333426-8_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT